Frencken Group has reported earnings of $14.8 million for the 3QFY2021 ended September, 10.7% higher than earnings of $13.3 million in the 3QFY2020.
Revenue for the 3QFY2021 increased by 18.7% y-o-y to $196.5 million due to the higher sales of the semiconductor, analytical and medical segments. The figure was partly offset by softer sales of the industrial automation and automotive segments.
See: Frencken Group acquires high-precision manufacturing solutions provider Avimac for $14 mil
PATMI margin for the 3QFY2021 fell 0.6 percentage points to 7.5%.
For the 9MFY2021, earnings surged 43.7% y-o-y to $46.1 million.
Revenue improved 24.8% y-o-y during the nine-month period to $571.8 million.
See also: Trump wins Republican nomination, setting up rematch with Biden
PATMI margin grew 1.1 percentage points to 8.1% due to the group’s revenue growth, which resulted in overhead costs being spread over a larger revenue base.
As at end-September, Frencken’s cash and cash equivalents stood at $169.2 million.
For more stories about where the money flows, click here for our Capital section
In its outlook statement, the group expects its overall revenue in the 2HFY2021 to remain stable, compared to that of 1HFY2021.
Shares in Frencken closed 13 cents higher or 5.96% up at $2.31 on Nov 11.
